Retinitis Pigmentosa
portes grátis
Retinitis Pigmentosa
Quinn, Peter M.J.; Tsang, Stephen H.
Springer-Verlag New York Inc.
12/2022
404
Dura
Inglês
9781071626504
15 a 20 dias
990
Descrição não disponível.
Introduction and History of Retinitis Pigmentosa.- Etiology of Retinitis Pigmentosa.- Clinical Evaluation of Patients with Retinitis Pigmentosa.- Molecular Genetic Testing Approaches for Retinitis Pigmentosa.- Pedigree Analysis of Families and Patients Affected by Retinitis Pigmentosa.- Whole Genome Sequencing for Detection of Structural Variants in Patients with Retinitis Pigmentosa.- Fundus Imaging Methodologies to Assess RP patients.- The Use of Optical Coherence Tomography in Evaluation of Retinitis Pigmentosa.- Optical Coherence Tomography Angiography (OCTA) findings in Retinitis Pigmentosa.- ERG to Evaluate the Retina in Cases of Retinitis Pigmentosa.- Visual Function Tests: Visual Fields.- Visual Function Tests.- Visual Acuity as a Measurement of Visual Function.- Measure of Visual Function.- Ophthalmic Fluorescein Angiography.- Indocyanine Green Angiography.- Use of the Medmont Dark-Adapted Chromatic Perimeter for Assessing Rod Function in Retinitis Pigmentosa.- Multi-Luminance Mobility Testing Endpoint.- Preclinical Models of Retinitis Pigmentosa.- ERG to evaluate the retina using mouse models.- Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent.- Large animal models of retinitis pigmentosa in therapy development and preclinical testing.- CRISPR manipulations in stem cell lines.- CRISPR-mediated genome engineering in cell lines.- CRISPR off-targeting.- CRISPR manipulations in stem cell lines.- Generation of Human iPSC-Derived Retinal Organoids for Assessment of AAV-Mediated Gene Delivery.- Culture of Human Retinal Explants for Ex Vivo Assessment of AAV Gene Delivery.- Prime Editing for the Installation and Correction of Mutations causing Inherited Retinal Disease: A Brief Methodology.- Large scale single-nucleus RNA sequencing compatible with complex archived samples.- Vector Shedding and Immunogenicity Sampling in AAV-based Gene Therapy for Retinitis Pigmentosa Patients.- Current Management Options for Patients with Retinitis Pigmentosa.- Challenges of Treatment Methodologies and the Future of Gene Therapy and Stem Cell Therapy to Treat Retinitis Pigmentosa.- Ocular Injection Techniques for Retinitis Pigmentosa: Intravitreal, Subretinal, and Suprachoroidal.- Surgical Approach with Pars Plana Vitrectomy for Subretinal Gene Therapy.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
CRISPR;stem cell therapy;stem cell therapy;Optical Coherence Tomography;Pathogenic Variants
Introduction and History of Retinitis Pigmentosa.- Etiology of Retinitis Pigmentosa.- Clinical Evaluation of Patients with Retinitis Pigmentosa.- Molecular Genetic Testing Approaches for Retinitis Pigmentosa.- Pedigree Analysis of Families and Patients Affected by Retinitis Pigmentosa.- Whole Genome Sequencing for Detection of Structural Variants in Patients with Retinitis Pigmentosa.- Fundus Imaging Methodologies to Assess RP patients.- The Use of Optical Coherence Tomography in Evaluation of Retinitis Pigmentosa.- Optical Coherence Tomography Angiography (OCTA) findings in Retinitis Pigmentosa.- ERG to Evaluate the Retina in Cases of Retinitis Pigmentosa.- Visual Function Tests: Visual Fields.- Visual Function Tests.- Visual Acuity as a Measurement of Visual Function.- Measure of Visual Function.- Ophthalmic Fluorescein Angiography.- Indocyanine Green Angiography.- Use of the Medmont Dark-Adapted Chromatic Perimeter for Assessing Rod Function in Retinitis Pigmentosa.- Multi-Luminance Mobility Testing Endpoint.- Preclinical Models of Retinitis Pigmentosa.- ERG to evaluate the retina using mouse models.- Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent.- Large animal models of retinitis pigmentosa in therapy development and preclinical testing.- CRISPR manipulations in stem cell lines.- CRISPR-mediated genome engineering in cell lines.- CRISPR off-targeting.- CRISPR manipulations in stem cell lines.- Generation of Human iPSC-Derived Retinal Organoids for Assessment of AAV-Mediated Gene Delivery.- Culture of Human Retinal Explants for Ex Vivo Assessment of AAV Gene Delivery.- Prime Editing for the Installation and Correction of Mutations causing Inherited Retinal Disease: A Brief Methodology.- Large scale single-nucleus RNA sequencing compatible with complex archived samples.- Vector Shedding and Immunogenicity Sampling in AAV-based Gene Therapy for Retinitis Pigmentosa Patients.- Current Management Options for Patients with Retinitis Pigmentosa.- Challenges of Treatment Methodologies and the Future of Gene Therapy and Stem Cell Therapy to Treat Retinitis Pigmentosa.- Ocular Injection Techniques for Retinitis Pigmentosa: Intravitreal, Subretinal, and Suprachoroidal.- Surgical Approach with Pars Plana Vitrectomy for Subretinal Gene Therapy.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
